The Fulani are less clinically susceptible and more immunologically responsive to malaria than neighbouring ethnic groups. Here we report that anti-malarial antibody levels show a wide distribution amongst the Fulani themselves, raising the possibility that quantitative analysis within the Fulani may be an efficient way of screening for important genetic factors. The Th2 cytokine interleukin-4 is an obvious candidate: in Fulani, the IL4-524 T allele is at high frequency and is associated with elevated antibody levels against malaria antigens. These data highlight the possibility of combining interand intra-ethnic comparisons to characterize critical determinants of malarial immunity in a natural setting. Genes and Immunity (2001) 2, 411-414.
The Fulani of West Africa have fewer malaria attacks and lower prevalence of Plasmodium falciparum infection than their neighbours, the Mossi and Rimaibé. 1, 2 Our previous studies in Burkina Faso indicate that this is not due to differences in malaria exposure or socio-cultural circumstances; 1, 2 in the population that we studied, the results of extensive entomologic surveys, carried out during two transmission seasons and the intervening dry seasons, showed similar inoculation rates for the three ethnic groups. Various markers confirm that the Fulani are genetically distinct from Mossi and Rimaibé, 3, 4 and it might be supposed that known genetic risk factors would be at higher frequency in the Fulani, but the reverse is true. 4 This suggests that powerful unknown genetic factor(s) may be involved, and the problem is how to dissect the causal factor from irrelevant genetic differences between these ethnic groups.
A possible functional basis for malaria protection in the Fulani is their very high antibody response to malarial antigens. 5, 6 This is illustrated in Figure 1 which reanalyses previous data to show inter-and intra-ethnic antibody distributions in two rural villages of Burkina Faso. 2, 5 This analysis was confined to individuals over 10 years old since antibody levels rise sharply in childhood, and the reduced malaria prevalence of the Fulani is most prominent in teenagers and adults. Although antibody levels are significantly higher in the Fulani (P Ͻ 0.001 for all three antigens by Kruskal-Wallis test) there is considerable overlap between the two groups. A few nonFulani have antibody levels that are close to those of the highest Fulani. The difference is more marked at the lower end of the distribution, where approximately 30% of non-Fulani values fall beneath the lowest Fulani value.
What sort of genetic effect might explain these distributions? If there is a single antibody-boosting determinant that is present in all Fulani and none of their neighbours, then the overlap must be entirely due to nongenetic factors. A second explanation for two overlapping distributions could be many different determinants which vary in frequency between the two groups. A third possibility would be a single major determinant that is present in a high proportion of Fulani and at lower frequency in other groups. Here we would expect to see the Fulani and non-Fulani at opposite ends of a bi-or trimodal distribution of antibody levels, with some overlap in the middle. Detailed family studies are needed to resolve this but it is worth noting that our data for the blood stage antigens are suggestive of the third possibility, and it is therefore of interest to consider candidate alleles that are present in all groups, but more commonly in the Fulani.
These considerations raise the possibility that quantitative analysis within the Fulani may be an efficient way of identifying genetic factors that boost malarial immun- Values are log-transformed and normalized to lie in the range 0 to 1. Blood samples were collected in K3-EDTA sterile tubes. Within 3-4 h after bleeding, the plasma was transferred and kept at −20°C until serological tests were done. The CSP (NANP) 40 , RESA (EENV) 6 and Pf332 (SVTEEIAEEDK) 2 antibody response was evaluated by ELISA. 5 The cut-off value for seropositivity was the mean plus three standard deviations of the values obtained on 30 negative Italian sera.
ity. Interleukin-4 (IL-4) is an obvious candidate. This Th2 cytokine induces Ig class switching from IgM/IgG to IgE and enhances the antigen-presenting capacity of B lymphocytes.
7 IL-4 gene and nearby markers located in the 5q region have been linked to elevated total IgE levels. 8, 9 In malaria-infected individuals, activation of IL-4 producing T-cell subsets has been associated with the production of anti-Pf-155/RESA-specific antibodies. 10 Furthermore, the 5q31-q33 region has been linked to P. falciparum infection intensity. 11, 12 A single nucleotide polymorphism (SNP) located at −524nt relative to the IL4 transcription start site has been reported to affect promoter activity, and the minor variant (here referred to as the IL4−524T allele) has been associated with elevated levels of total IgE. 13 The IL4+33 C allele was at slightly lower frequency in the Fulani (0.34) than in the Mossi (0.42) or Rimaibé (0.48) but this was not statistically significant. Both polymorphisms were in Hardy-Weinberg equilibrium and the IL4−524 T and IL4+33 C alleles were in significant linkage disequilibrium (P Ͻ 0.01 ). Table 1 shows the relationship between IL4 genotype and antimalarial IgG levels. In the Fulani, the IL4−524 T allele was associated with significantly higher levels of antibodies against CSP and Pf332 antigens (P = 0.03 and 0.01 respectively, by Kruskal-Wallis test). A similar trend was seen for RESA antibodies but this was not statistically significant. Consistent with the pattern of linkage disequilibrium, there was a non-significant trend towards higher antibody levels for the IL4+33 C allele. In Mossi or Rimaibé, no associations were observed.
The 5q31-q33 gene region has been linked to malaria infection intensity in independent family studies in Burkina Faso. 11, 12 IL4, which lies within this region, acts to promote antibody development and isotype switching, and is clearly of potential relevance to the high antimalarial antibody levels found in the Fulani. Human epidemiological data and murine experimental models indicate that IL4 plays a key role in the induction of specific antibodies during blood stage malaria, 10, [16] [17] [18] 19 although its role as a determinant of clinical outcome remains uncertain. The IL4−524 T allele is present in 75% of the Fulani, twice the frequency in their neighbours, raising the possibility that in this ethnic group it marks out a protective haplotype. Its association with elevated antibody levels in the Fulani would be consistent with this, while the lack of association in non-Fulani indicates that it is not itself the functional polymorphism. That could potentially lie in another part of the Th2 cytokine cluster which comprises genes such as IL13 or IL5, and coregulatory region as CNS-1. 20 In order to identify functional polymorphism/s in linkage disequilibrium with the SNPs analysed, a map of nucleotide and haplotype diversity of the 5q31-q33 region in the three populations is in progress. Whilst the data reported here require replication, they serve to highlight the potential value of combining inter-and intra-ethnic approaches to identify genetic determinants of immune responsiveness, and they support the view that the 5q31-q33 region is an important locus for further investigation in malaria. The IL4−524 and IL4+33 polymorphisms were typed in 159 unrelated individuals (11 to 79 years old). IL4-524 was typed by PCR amplification of a 512-bp fragment (forward AAA TAA AAA TAA AAA TGA GC, reverse CTG GGG AAA GAT AGA GTA ACT) and digestion with BsmF I. IL4+33 was typed by PCR amplification (forward GTG CTG ATT GGC CCC AAG TGA CTG, reverse TGG ACT GCC ACC AAC CAC CAG T) and digestion with Bsma I. The number of individuals for each genotype is in round brackets and mean age between square brackets. P value refers to Kruskal-Wallis test.
